Prompt response to rituximab in a patient with resistant polymyositis with complications of dysphagia and dysphonia: a case report
Primary treatment for cases of polymyositis typically involves the use of glucocorticoids. However, approximately half of the patients do not respond adequately to corticosteroids alone. Alternatives, in such cases, encompass IVIG therapy and rituximab.
Authors
- Layth Jamil Mohammad Saada (ORCID: https://orcid.org/0000-0001-8776-8095)
- Yousef Mahmoud Nimer Habes (ORCID: https://orcid.org/0000-0002-4688-0416)
- Saed I Y Attawna
- Mohammed Abdulrazzak (ORCID: https://orcid.org/0000-0003-0807-9000)
- Ali Jamil Ali Mali
- Saif Ibraheem Mohammad Sadeh
Institutions
- University of Aleppo (SY)
- Al-Quds University (PS)
- Al-Ahli Hospital (QA)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1097/ms9.0000000000002490
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00